CN103071003B - 一种活血化瘀、通经活络的中药 - Google Patents
一种活血化瘀、通经活络的中药 Download PDFInfo
- Publication number
- CN103071003B CN103071003B CN 201310045350 CN201310045350A CN103071003B CN 103071003 B CN103071003 B CN 103071003B CN 201310045350 CN201310045350 CN 201310045350 CN 201310045350 A CN201310045350 A CN 201310045350A CN 103071003 B CN103071003 B CN 103071003B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- blood
- taken
- collaterals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 210000004369 blood Anatomy 0.000 title abstract description 25
- 239000008280 blood Substances 0.000 title abstract description 25
- 230000017531 blood circulation Effects 0.000 title abstract description 20
- 230000001737 promoting effect Effects 0.000 title abstract description 20
- 230000003213 activating effect Effects 0.000 title abstract description 6
- 239000004863 Frankincense Substances 0.000 claims abstract description 6
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 5
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 5
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241000227129 Aconitum Species 0.000 claims description 8
- 240000000031 Achyranthes bidentata Species 0.000 claims description 7
- 241000208688 Eucommia Species 0.000 claims description 6
- 244000020518 Carthamus tinctorius Species 0.000 claims description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 231100000862 numbness Toxicity 0.000 abstract description 25
- 229940079593 drug Drugs 0.000 abstract description 22
- 208000002193 Pain Diseases 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- 240000007311 Commiphora myrrha Species 0.000 abstract description 4
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 4
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 4
- 244000170916 Paeonia officinalis Species 0.000 abstract description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 3
- 206010010904 Convulsion Diseases 0.000 abstract description 3
- 241000208689 Eucommia ulmoides Species 0.000 abstract description 3
- 230000036461 convulsion Effects 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000000149 penetrating effect Effects 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000489492 Arisaema Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 230000002175 menstrual effect Effects 0.000 abstract 1
- 230000004220 muscle function Effects 0.000 abstract 1
- 230000007830 nerve conduction Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 208000034783 hypoesthesia Diseases 0.000 description 33
- 208000004044 Hypesthesia Diseases 0.000 description 23
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 210000002683 foot Anatomy 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 241000361919 Metaphire sieboldi Species 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 208000024765 knee pain Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010029240 Neuritis Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 235000007672 methylcobalamin Nutrition 0.000 description 2
- 239000011585 methylcobalamin Substances 0.000 description 2
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 208000000185 Localized scleroderma Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 125000003346 cobalamin group Chemical group 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008563 guizhi decoction Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
| 组别 | 例数 | 治愈 | 显效 | 有效 | 无效 | 总有效率(%) |
| 治疗组 | 40 | 22 | 9 | 6 | 3 | 92.50 |
| 对照组 | 30 | 9 | 6 | 7 | 8 | 73.33 |
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310045350 CN103071003B (zh) | 2013-02-05 | 2013-02-05 | 一种活血化瘀、通经活络的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310045350 CN103071003B (zh) | 2013-02-05 | 2013-02-05 | 一种活血化瘀、通经活络的中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103071003A CN103071003A (zh) | 2013-05-01 |
| CN103071003B true CN103071003B (zh) | 2013-10-23 |
Family
ID=48147848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310045350 Expired - Fee Related CN103071003B (zh) | 2013-02-05 | 2013-02-05 | 一种活血化瘀、通经活络的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103071003B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491641A (zh) * | 2014-12-29 | 2015-04-08 | 西安石油大学 | 一种促进肌肉拉伤愈合的熏洗药物 |
| CN105456933A (zh) * | 2015-12-23 | 2016-04-06 | 青岛友诚高新技术有限公司 | 一种活血化瘀、通经活络的中药及其制备方法 |
| CN106138637B (zh) * | 2016-08-22 | 2020-01-07 | 陕西盘龙药业集团股份有限公司 | 一种活血化瘀抗风湿止痛的中药组合物及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895642A (zh) * | 2005-07-12 | 2007-01-17 | 侯保君 | 一种治疗颈肩腰腿痛的中药组合物及其制备方法 |
-
2013
- 2013-02-05 CN CN 201310045350 patent/CN103071003B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895642A (zh) * | 2005-07-12 | 2007-01-17 | 侯保君 | 一种治疗颈肩腰腿痛的中药组合物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 严婉英等.治痹十法.《河北中医》.1998,第20卷(第01期), |
| 治痹十法;严婉英等;《河北中医》;19980115;第20卷(第01期);30-31 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103071003A (zh) | 2013-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103070965B (zh) | 一种消肿止痛、活血通络的中药 | |
| CN103705751B (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
| CN102973750B (zh) | 治疗风湿、类风湿以及痛风性关节炎和颈椎病的中药 | |
| CN103071003B (zh) | 一种活血化瘀、通经活络的中药 | |
| CN102805817B (zh) | 治疗风湿和类风湿疾病的药物 | |
| CN104258278A (zh) | 骨伤灵喷雾剂 | |
| CN105343466A (zh) | 一种治疗冠心病的中药组合物 | |
| CN104147261B (zh) | 一种治疗风湿性关节炎的中药制剂 | |
| CN105617322A (zh) | 一种治疗牛皮癣的中药组合物及其制备方法 | |
| CN102526382A (zh) | 一种消肿止痛的膏药 | |
| CN102824599B (zh) | 一种治疗糖尿病引起的各种皮肤溃烂的中药酊剂 | |
| CN1297309C (zh) | 关节痹络通外用药组合物及其制备方法 | |
| CN101559185A (zh) | 一种治疗下肢静脉曲张的外用药物 | |
| CN106266388B (zh) | 一种治疗骨痹、活血止痛的外搽药酒及其制备方法 | |
| CN102406773B (zh) | 一种消肿化瘀外洗中药 | |
| CN119405720A (zh) | 一种防治下肢深静脉血栓的中药组合物及其应用 | |
| CN107998235A (zh) | 治疗踝关节扭伤的复方壮药物及其制备方法 | |
| CN106955314A (zh) | 活血清热川黄散 | |
| CN105412417A (zh) | 一种治疗腱鞘炎的中药软膏及其制备方法 | |
| CN107198763A (zh) | 一种防治小腿静脉曲张的外用中药及其制备方法 | |
| CN119818625A (zh) | 一种预防和缓解关节不适的外用组合物及其制备方法 | |
| CN105412416A (zh) | 一种风湿性关节炎的中药洗剂及其制备方法 | |
| CN103948907A (zh) | 能有效治疗冻疮、冻伤的外用中药散剂及制备方法 | |
| CN118178494A (zh) | 一种治疗手足综合征的中药组合物 | |
| CN104587093A (zh) | 一种治疗急性软组织损伤的外用中药散剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANDONG UNIVERSITY Free format text: FORMER OWNER: XIN QING Effective date: 20130917 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250061 JINAN, SHANDONG PROVINCE TO: 250100 JINAN, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130917 Address after: Licheng Alexander Road in Ji'nan City, Shandong province 250100 No. 27 Applicant after: Shandong University Address before: 250061 School Hospital of Shandong University Qianfo Hill campus, No. ten, 17923, Shandong, Ji'nan Applicant before: Xin Qing |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131023 Termination date: 20150205 |
|
| EXPY | Termination of patent right or utility model |